XGN Exagen Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 4, 2026
$8.17
· of 52w range
· above low
· to high
$2.5952w low
$12.2352w high
Market Cap (MRQ)
$198M
P/E (TTM)
-10.0
EPS (TTM)
$-0.82
Revenue (TTM)
$71M
your badges
52W Range
$3–$12
Analyst Rating
BUY
Price Target
$10
P/E
-10.0
ROE
-113.8%
Net Profit Margin
-26.6%
Your badge strip is empty — pin a metric anywhere on this page.
XGN Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$8.17
Market Cap (MRQ)
$198M
P/E (TTM)
-10.0
EPS (TTM)
$-0.82
Revenue (TTM)
$71M
ROE (TTM)
-113.8%
Debt/Equity (MRQ)
1.9
52W Range
$3–$12
XGN Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
About Exagen Inc. - Common Stock Company overview from Wikipedia
sectorHealthcare
industryBiotechnology
employees216
countryUS
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$67M2018-12-31 → 2025-12-31
EPS$-0.932020-12-31 → 2025-12-31
Free Cash Flow$-14M2019-12-31 → 2025-12-31
Net margin-26.6%2019-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | XGN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | -10.05Y avg ≈-3.5 | ≈-3.5 | · | · | |
| P/S (TTM) | 2.85Y avg ≈1.2 | ≈1.2 | 66.2 | Undervalued | |
| P/B (MRQ) | 16.25Y avg ≈4.5 | ≈4.5 | 3.2 | Overvalued | |
| EV / EBITDA | -15.75Y avg ≈-4.4 | ≈-4.4 | · | · | |
| Price / FCF (TTM) | -26.05Y avg ≈-4.6 | ≈-4.6 | · | · | |
| Price / Cash Flow (TTM) | -30.45Y avg ≈-4.8 | ≈-4.8 | · | · | |
| EV / Revenue | 2.85Y avg ≈0.9 | ≈0.9 | · | · | |
| EV / FCF | -13.15Y avg ≈-3.9 | ≈-3.9 | · | · | |
| Price / Tangible Book | 11.35Y avg ≈4.5 | ≈4.5 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | XGN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Gross Margin (TTM) | 58.6% | · | · | · | |
| Operating Margin (TTM) | -18.6%5Y avg ≈-47.5% | ≈-47.5% | -1088.2% | Top tier | |
| EBITDA Margin (TTM) | -15.2%5Y avg ≈-44.1% | ≈-44.1% | -1088.2% | Top tier | |
| Net Profit Margin (TTM) | -26.6%5Y avg ≈-51.6% | ≈-51.6% | -988.2% | Top tier | |
| ROA (TTM) | -34.2%5Y avg ≈-37.7% | ≈-37.7% | -45.0% | Top tier | |
| ROE (TTM) | -113.8%5Y avg ≈-107.3% | ≈-107.3% | -70.4% | Weak |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | XGN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Debt / Equity (MRQ) | 1.95Y avg ≈1.2 | ≈1.2 | 0.0 | High debt | |
| Current Ratio (MRQ) | 3.25Y avg ≈4.4 | ≈4.4 | 7.3 | Low liquidity | |
| Quick Ratio | 3.05Y avg ≈4.0 | ≈4.0 | 5.0 | Low liquidity | |
| Long-Term Debt / Equity (MRQ) | 1.85Y avg ≈1.2 | ≈1.2 | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | XGN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | 19.7%5Y avg ≈8.8% | ≈8.8% | · | · | |
| Revenue CAGR 3Y | 13.5%5Y avg ≈8.7% | ≈8.7% | · | · | |
| Revenue CAGR 5Y | 9.7% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | XGN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 1.35Y avg ≈0.9 | ≈0.9 | 0.1 | Top tier | |
| Receivables Turnover | 7.15Y avg ≈7.3 | ≈7.3 | · | · | |
| Revenue / Employee | ≈$308.2K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-12.6%
Next Report
Nov 02, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Jul 27, 2026 | $-0.13 | $-0.19 | 32.3% |
| March 31, 2026 | May 12, 2026 | $-0.20 | $-0.24 | 15.1% |
| Dec. 31, 2025 | $-0.20 | $-0.19 | -4.2% | |
| Sept. 30, 2025 | $-0.31 | $-0.16 | -94.8% | |
| June 30, 2025 | $-0.18 | $-0.14 | -26.0% | |
| March 31, 2025 | $-0.20 | $-0.20 | 1.8% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $67M | $56M | $53M | $46M | $48M | $42M | $40M | $32M | |
| Cost of Revenue | $28M | $23M | $23M | $24M | $21M | $17M | $19M | $15M | |
| Gross Profit | $39M | $33M | $29M | · | · | · | · | · | |
| R&D Expense | $6M | $5M | $5M | $10M | $7M | $4M | $2M | $2M | |
| SG&A Expense | $47M | $41M | $47M | $52M | $45M | $37M | $29M | $20M | |
| Operating Expenses | $53M | $47M | $52M | $92M | $72M | $57M | $50M | $37M | |
| Operating Income | $-14M | $-14M | $-23M | $-46M | $-24M | $-15M | $-9M | $-5M | |
| Interest Expense | · | · | $2M | $2M | $3M | $3M | $3M | $3M | |
| Interest Income | $289.0K | $767.0K | $2M | · | · | · | · | · | |
| Other Non-op | · | · | · | · | $16.0K | $984.0K | $510.0K | $112.0K | |
| Income Tax | $51.0K | $12.0K | $33.0K | $-282.0K | $175.0K | $-79.0K | $25.0K | $58.0K | |
| Net Income | $-20M | $-15M | $-24M | $-47M | $-27M | $-17M | $-12M | $-8M | |
| EPS (Basic) | $-0.93 | $-0.83 | $-1.34 | $-2.77 | $-1.68 | $-1.32 | · | · | |
| EPS (Diluted) | $-0.93 | $-0.83 | $-1.34 | $-2.77 | $-1.68 | $-1.32 | · | · | |
| Shares (Basic) | 21,558,245 | 18,203,044 | 17,679,467 | 17,082,348 | 15,972,256 | 12,632,780 | · | · | |
| Shares (Diluted) | 21,558,245 | 18,203,044 | 17,679,467 | 17,082,348 | 15,972,256 | 12,632,780 | · | · | |
| EBITDA | $-12M | $-12M | $-21M | $-44M | $-23M | · | $-9M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $32M | $22M | $36M | $62M | $99M | $57M | $72M | $13M | |
| Receivables | $11M | $8M | $7M | $6M | $10M | $9M | $6M | $6M | |
| Prepaid Expense | $6M | $7M | $5M | $4M | $4M | $4M | $3M | $2M | |
| Other Current Assets | $3M | $6M | $3M | $2M | $1M | $1M | $1M | $1M | |
| Current Assets | $49M | $36M | $48M | $73M | $113M | $71M | $81M | $21M | |
| PP&E (Net) | · | · | · | $8M | $5M | $2M | $1M | $2M | |
| PP&E (Gross) | · | · | · | $13M | $9M | $5M | $4M | $3M | |
| Accum. Depreciation | · | · | · | $5M | $4M | $3M | $2M | $2M | |
| Goodwill | · | · | · | $0 | $6M | $6M | $6M | $6M | |
| Other Non-current Assets | $756.0K | $550.0K | $616.0K | $528.0K | $433.0K | $250.0K | $174.0K | $503.0K | |
| Total Assets | $58M | $45M | $57M | $86M | $123M | $78M | $88M | $29M | |
| Accounts Payable | $4M | $4M | $3M | $3M | $2M | $3M | $1M | $1M | |
| Accrued Liabilities | $6M | $7M | $8M | $5M | $7M | $6M | $4M | $4M | |
| Current Liabilities | $14M | $14M | $12M | $10M | $9M | $9M | $6M | $9M | |
| Capital Leases | $438.0K | $2M | $3M | $4M | $0 | $576.0K | $636.0K | · | |
| Deferred Tax | · | · | · | $0 | $306.0K | $158.0K | $264.0K | $245.0K | |
| Other Non-current Liabilities | · | $157.0K | $357.0K | $867.0K | $1M | $948.0K | $638.0K | $304.0K | |
| Total Liabilities | $41M | $35M | $34M | $44M | $39M | $37M | $33M | $36M | |
| Long-term Debt | $23M | $20M | $19M | $29M | $27M | $27M | $26M | · | |
| Total Debt | $23M | $20M | $19M | $29M | $27M | · | $26M | · | |
| Common Stock | $23.0K | $18.0K | $17.0K | $17.0K | $16.0K | $13.0K | $13.0K | $0 | |
| Paid-in Capital | $332M | $304M | $302M | $298M | $293M | $223M | $220M | $41M | |
| Retained Earnings | $-314M | $-294M | $-279M | $-256M | $-208M | $-181M | $-165M | $-153M | |
| Stockholders' Equity | $17M | $10M | $23M | $42M | $85M | $42M | $56M | $-112M | |
| Liabilities + Equity | $58M | $45M | $57M | $86M | $123M | $78M | $88M | $29M | |
| Shares Outstanding | 22,911,575 | 17,640,328 | 17,045,954 | 16,549,984 | 16,164,994 | 12,652,308 | 12,560,990 | 63,005 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $900.0K | $500.0K | $600.0K | $600.0K | |
| Stock-based Comp | $2M | $2M | $4M | $5M | $5M | $3M | $572.0K | $114.0K | |
| Deferred Tax | $0 | $0 | $0 | $-306.0K | $148.0K | $-106.0K | $20.0K | $31.0K | |
| Amort. of Intangibles | · | · | · | · | · | · | $0 | $141.0K | |
| Other Non-cash | $2M | $-2M | $3M | $9M | $806.0K | · | $1M | · | |
| Operating Cash Flow | $-14M | $-13M | $-14M | $-32M | $-20M | $-14M | $-10M | $-9M | |
| CapEx | $641.0K | $515.0K | $828.0K | $4M | $2M | $455.0K | $403.0K | $199.0K | |
| Investing Cash Flow | $-626.0K | $-515.0K | $-804.0K | $-4M | $-2M | $-455.0K | $-103.0K | $-199.0K | |
| Debt Issued | · | · | · | · | · | · | $0 | $5M | |
| Net Debt Issued | · | $0 | $-10M | · | · | · | $0 | · | |
| Stock Issued | $3M | $0 | · | $0 | $69M | $0 | · | · | |
| Net Stock Activity | $3M | · | · | $0 | $69M | · | · | · | |
| Financing Cash Flow | $24M | $-663.0K | $-11M | $-489.0K | $65M | $-97.0K | $69M | $11M | |
| Net Change in Cash | $10M | $-14M | $-26M | $-37M | $42M | $-15M | $59M | $2M | |
| Taxes Paid | $35.0K | $32.0K | · | · | · | · | · | · | |
| Free Cash Flow | $-14M | $-14M | $-15M | $-36M | $-23M | · | $-10M | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 58.3% | 59.5% | · | · | · | · | · | · | |
| Operating Margin | -21.1% | -24.5% | -43.5% | -101.1% | -49.8% | · | -23.0% | · | |
| Net Margin | -30.0% | -27.2% | -45.1% | -104.0% | -55.6% | · | -29.8% | · | |
| EBITDA Margin | -18.0% | -21.4% | -39.3% | -97.6% | -48.0% | · | -21.5% | · | |
| ROA | -38.9% | -29.7% | -33.1% | -49.1% | -26.6% | · | -20.5% | · | |
| ROE | -103.7% | -134.9% | -94.4% | -96.1% | -30.6% | · | -21.1% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.5 | 2.7 | 4.0 | 7.5 | 12.1 | · | 13.8 | · | |
| Quick Ratio | 3.0 | 2.2 | 3.6 | 7.1 | 11.7 | · | 13.2 | · | |
| Debt / Equity | 1.3 | 2.1 | 0.9 | 0.7 | 0.3 | · | 0.5 | · | |
| LT Debt / Equity | 1.3 | 2.1 | 0.8 | 0.7 | 0.3 | · | 0.5 | · | |
| Interest Coverage | · | · | -9.8 | -18.8 | -9.2 | · | -2.7 | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.3 | 1.1 | 0.7 | 0.5 | 0.5 | · | 0.7 | · | |
| Receivables Turnover | 7.1 | 7.7 | 8.3 | 6.2 | 5.2 | · | 6.9 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.76 | $0.54 | $1.33 | $2.57 | $5.25 | · | $4.43 | · | |
| Revenue / Share | $3.09 | $3.06 | $2.97 | $2.67 | $3.02 | · | · | · | |
| Cash Flow / Share | $-0.63 | $-0.73 | $-0.82 | $-1.88 | $-1.27 | · | · | · | |
| Cash / Share | $1.41 | $1.25 | $2.14 | $3.77 | $6.15 | · | $5.74 | · | |
| EPS (TTM) | $-0.93 | $-0.83 | $-1.34 | $-2.77 | $-1.68 | $-1.32 | · | · |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 19.7% | 5.9% | 15.3% | -5.7% | 15.1% | · | · | · | |
| Revenue CAGR 3Y | 13.5% | 4.8% | 7.8% | · | · | · | · | · | |
| Revenue CAGR 5Y | 9.7% | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $67M | $56M | $53M | $46M | $48M | $42M | $40M | · | |
| Net Income TTM | $-20M | $-15M | $-24M | $-47M | $-27M | $-17M | $-12M | · | |
| Market Cap | $139M | $72M | $34M | $40M | $188M | · | $319M | · | |
| Enterprise Value | $130M | $71M | $17M | $6M | $116M | · | $273M | · | |
| P/E | -6.5 | -4.9 | -1.5 | -0.9 | -6.9 | -10.0 | · | · | |
| P/S | 2.1 | 1.3 | 0.6 | 0.9 | 3.9 | · | 7.9 | · | |
| P/B | 8.0 | 7.6 | 1.5 | 0.9 | 2.2 | · | 5.7 | · | |
| P / Tangible Book | 8.0 | 7.6 | 1.5 | 0.9 | 2.4 | 4.6 | · | · | |
| P / Cash Flow | -10.2 | -5.4 | -2.3 | -1.2 | -9.3 | · | -32.9 | · | |
| P / FCF | -9.8 | -5.2 | -2.2 | -1.1 | -8.3 | · | -31.5 | · | |
| EV / EBITDA | -10.9 | -5.9 | -0.8 | -0.1 | -5.0 | · | -31.4 | · | |
| EV / FCF | -9.1 | -5.1 | -1.1 | -0.2 | -5.1 | · | -27.0 | · | |
| EV / Revenue | 2.0 | 1.3 | 0.3 | 0.1 | 2.4 | · | 6.8 | · | |
| Earnings Yield | -15.3% | -20.2% | -67.3% | -115.4% | -14.4% | -10.0% | · | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $20M | $17M | $17M | $17M | $17M | $15M | $14M | $13M | $15M | $14M | $14M | $13M | $14M | $11M | $13M | $15M | |
| Cost of Revenue | $8M | $7M | $7M | $7M | $7M | $6M | $5M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | |
| Gross Profit | $12M | $10M | $9M | $10M | $10M | $9M | $8M | $7M | $9M | $9M | · | · | · | · | · | · | |
| R&D Expense | $1M | $2M | $2M | $2M | $1M | $1M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $3M | $2M | |
| SG&A Expense | $13M | $12M | $12M | $11M | $12M | $11M | $10M | $10M | $10M | $11M | $12M | $11M | $12M | $12M | $13M | $14M | |
| Operating Expenses | $14M | $14M | $14M | $13M | $13M | $12M | $12M | $12M | $12M | $12M | $-4M | $18M | $19M | $19M | $27M | $23M | |
| Operating Income | $-2M | $-3M | $-5M | $-3M | $-3M | $-3M | $-3M | $-5M | $-3M | $-3M | $-5M | $-5M | $-5M | $-8M | $-14M | $-8M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $549.0K | · | $557.0K | $574.0K | $638.0K | $626.0K | $618.0K | |
| Interest Income | · | · | $43.0K | $3.0K | $85.0K | $158.0K | $197.0K | $197.0K | $181.0K | $192.0K | $173.0K | $211.0K | $476.0K | · | · | · | |
| Other Non-op | $153.0K | $-132.0K | · | · | $85.0K | $158.0K | · | · | · | · | · | $211.0K | $476.0K | · | · | $339.0K | |
| Income Tax | $0 | $36.0K | $13.0K | $1.0K | $37.0K | $0 | $12.0K | $0 | $0 | · | · | · | · | · | · | · | |
| Net Income | $-3M | $-4M | $-5M | $-7M | $-4M | $-4M | $-4M | $-5M | $-3M | $-3M | $-6M | $-5M | $-5M | $-8M | $-14M | $-8M | |
| EPS (Basic) | $-0.13 | $-0.17 | $-0.21 | $-0.31 | $-0.21 | $-0.20 | $-0.20 | $-0.28 | $-0.16 | $-0.19 | $-0.31 | $-0.31 | $-0.28 | $-0.44 | $-0.84 | $-0.47 | |
| EPS (Diluted) | $-0.13 | $-0.17 | $-0.21 | $-0.31 | $-0.21 | $-0.20 | $-0.20 | $-0.28 | $-0.16 | $-0.19 | $-0.31 | $-0.31 | $-0.28 | $-0.44 | $-0.84 | $-0.47 | |
| Shares (Basic) | 24,164,569 | 23,854,997 | · | 22,940,412 | 21,085,749 | 18,557,390 | · | 18,254,937 | 18,178,185 | 17,944,438 | · | 17,692,603 | 17,655,483 | 17,526,763 | · | 17,080,959 | |
| Shares (Diluted) | 24,164,569 | 23,854,997 | · | 22,940,412 | 21,085,749 | 18,557,390 | · | 18,254,937 | 18,178,185 | 17,944,438 | · | 17,692,603 | 17,655,483 | 17,526,763 | · | 17,080,959 | |
| EBITDA | $-1M | $-3M | · | $-2M | $-2M | $-3M | · | $-4M | $-2M | $-3M | · | $-4M | $-4M | $-7M | · | $-7M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $25M | $22M | $32M | $36M | $30M | $11M | $22M | $22M | $24M | $27M | $36M | $28M | $31M | $52M | $62M | $69M | |
| Receivables | $12M | $16M | $11M | $11M | $14M | $15M | $8M | $9M | $12M | $11M | $7M | $17M | $16M | $9M | $6M | $11M | |
| Prepaid Expense | $6M | $6M | $6M | $6M | $7M | $7M | $7M | $4M | $5M | $4M | $5M | $3M | $4M | $4M | $4M | $3M | |
| Other Current Assets | $4M | $4M | $3M | $4M | $4M | $5M | $6M | $3M | $3M | $2M | $3M | $2M | $2M | $2M | $2M | $1M | |
| Current Assets | $43M | $44M | $49M | $53M | $51M | $33M | $36M | $36M | $41M | $42M | $48M | $49M | $51M | $66M | $73M | $82M | |
| Goodwill | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $6M | |
| Other Non-current Assets | $560.0K | $584.0K | $756.0K | $1M | $1M | $596.0K | $550.0K | $563.0K | $513.0K | $561.0K | $616.0K | $638.0K | $620.0K | $603.0K | $528.0K | $586.0K | |
| Total Assets | $52M | $52M | $58M | $63M | $59M | $40M | $45M | $44M | $49M | $51M | $57M | $61M | $64M | $79M | $86M | $102M | |
| Accounts Payable | $4M | $4M | $4M | $4M | $3M | $5M | $4M | $1M | $2M | $1M | $3M | $2M | $1M | $2M | $3M | $4M | |
| Accrued Liabilities | $5M | $5M | $6M | $6M | $5M | $5M | $7M | $6M | $6M | $6M | $8M | $7M | $6M | $6M | $5M | $7M | |
| Current Liabilities | $13M | $13M | $14M | $13M | $10M | $14M | $14M | $9M | $9M | $9M | $12M | $10M | $9M | $9M | $10M | $11M | |
| Capital Leases | $1M | $111.0K | $438.0K | $759.0K | $1M | $1M | $2M | $2M | $2M | $2M | $3M | $4M | $4M | $4M | $4M | $5M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $306.0K | |
| Other Non-current Liabilities | · | · | · | · | $91.0K | $122.0K | · | $185.0K | $219.0K | $268.0K | $357.0K | $484.0K | $597.0K | $726.0K | $867.0K | $999.0K | |
| Total Liabilities | $40M | $38M | $41M | $45M | $38M | $34M | $35M | $31M | $32M | $31M | $34M | $33M | $32M | $43M | $44M | $45M | |
| Long-term Debt | $23M | $23M | $23M | $23M | $23M | $21M | $20M | $20M | $20M | $20M | $19M | $19M | $19M | $29M | $29M | $28M | |
| Total Debt | $23M | $23M | · | $23M | $23M | $21M | · | $20M | $20M | $20M | · | $19M | $19M | $29M | · | $28M | |
| Common Stock | $24.0K | $24.0K | $23.0K | $23.0K | $22.0K | $18.0K | $18.0K | $18.0K | $17.0K | $17.0K | $17.0K | $17.0K | $17.0K | $17.0K | $17.0K | $16.0K | |
| Paid-in Capital | $334M | $333M | $332M | $328M | $324M | $304M | $304M | $303M | $303M | $303M | $302M | $301M | $300M | $299M | $298M | $297M | |
| Retained Earnings | $-321M | $-318M | $-314M | $-310M | $-303M | $-298M | $-294M | $-291M | $-286M | $-283M | $-279M | $-274M | $-268M | $-263M | $-256M | $-241M | |
| Stockholders' Equity | $12M | $14M | $17M | $18M | $21M | $6M | $10M | $13M | $18M | $20M | $23M | $28M | $32M | $36M | $42M | $56M | |
| Liabilities + Equity | $52M | $52M | $58M | $63M | $59M | $40M | $45M | $44M | $49M | $51M | $57M | $61M | $64M | $79M | $86M | $102M | |
| Shares Outstanding | 24,193,101 | 24,088,057 | 22,911,575 | 22,510,313 | 21,998,739 | 17,950,033 | 17,640,328 | 17,520,335 | 17,381,575 | 17,317,941 | 17,045,954 | 16,931,894 | 16,858,194 | 16,827,014 | 16,549,984 | 16,305,475 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $600.0K | $600.0K | $600.0K | $600.0K | $500.0K | $400.0K | $400.0K | $400.0K | $400.0K | $500.0K | $500.0K | $600.0K | $500.0K | $600.0K | $600.0K | $400.0K | |
| Stock-based Comp | $980.0K | $655.0K | $705.0K | $593.0K | $443.0K | $417.0K | $433.0K | $217.0K | $560.0K | $553.0K | $763.0K | $890.0K | $978.0K | $986.0K | $582.0K | $1M | |
| Other Non-cash | · | $-8M | · | · | · | $-8M | · | · | · | $-7M | · | · | · | $-4M | · | · | |
| Operating Cash Flow | $4M | $-10M | $-3M | $3M | $-3M | $-11M | $363.0K | $-2M | $-2M | $-9M | $8M | $-3M | $-10M | $-10M | $-6M | $-7M | |
| CapEx | $543.0K | $228.0K | $44.0K | $275.0K | $209.0K | $113.0K | $146.0K | $147.0K | $136.0K | $86.0K | $106.0K | $2.0K | $324.0K | $396.0K | $406.0K | $879.0K | |
| Investing Cash Flow | $-543.0K | $-228.0K | $-35.0K | $-275.0K | $-209.0K | $-107.0K | $-146.0K | $-147.0K | $-136.0K | $-86.0K | $-84.0K | $-2.0K | $-322.0K | $-396.0K | $-406.0K | $-879.0K | |
| Stock Issued | · | · | $-38.0K | $-15M | · | · | $0 | $0 | · | · | · | · | · | · | · | $0 | |
| Financing Cash Flow | $-370.0K | $-62.0K | $-384.0K | $3M | $22M | $-64.0K | $-216.0K | $-121.0K | $-226.0K | $-100.0K | $-220.0K | $-108.0K | $-10M | $-62.0K | $-173.0K | $-22.0K | |
| Net Change in Cash | $3M | $-11M | $-3M | $6M | $19M | $-11M | $1.0K | $-2M | $-3M | $-9M | $8M | $-3M | $-21M | $-10M | $-6M | $-8M | |
| Free Cash Flow | · | $-11M | · | · | · | $-11M | · | · | · | $-9M | · | · | · | $-10M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 61.3% | 59.0% | · | 58.4% | 60.4% | 58.9% | · | · | · | · | · | · | · | · | · | · | |
| Operating Margin | -8.6% | -19.7% | · | -18.0% | -15.3% | -21.7% | · | -37.3% | -17.2% | -20.8% | · | -37.8% | -34.8% | -68.6% | · | -53.1% | |
| Net Margin | -16.0% | -22.9% | · | -41.1% | -25.8% | -24.2% | · | -40.2% | -19.7% | -23.3% | · | -40.4% | -35.5% | -68.5% | · | -55.0% | |
| EBITDA Margin | -5.6% | -16.3% | · | -14.5% | -12.4% | -19.1% | · | -34.1% | -14.5% | -17.4% | · | -33.3% | -31.2% | -63.3% | · | -50.4% | |
| ROA | -5.8% | -8.6% | · | -13.3% | -8.2% | -8.2% | · | -9.6% | -5.2% | -5.2% | · | -6.7% | -5.9% | -7.6% | · | -7.1% | |
| ROE | -19.2% | -38.1% | · | -45.7% | -23.0% | -28.4% | · | -24.9% | -12.0% | -12.0% | · | -12.9% | -10.6% | -13.7% | · | -11.0% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.2 | 3.5 | · | 4.1 | 5.0 | 2.3 | · | 4.1 | 4.3 | 4.8 | · | 4.8 | 6.0 | 7.1 | · | 7.2 | |
| Quick Ratio | 2.7 | 3.0 | · | 3.6 | 4.3 | 1.9 | · | 3.6 | 3.8 | 4.3 | · | 4.5 | 5.5 | 6.6 | · | 7.0 | |
| Debt / Equity | 1.9 | 1.6 | · | 1.3 | 1.1 | 3.3 | · | 1.6 | 1.2 | 1.0 | · | 0.7 | 0.6 | 0.8 | · | 0.5 | |
| LT Debt / Equity | 1.8 | 1.5 | · | 1.2 | 1.1 | 2.9 | · | 1.5 | 1.1 | 1.0 | · | 0.7 | 0.6 | 0.8 | · | 0.5 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -5.5 | · | -9.1 | -8.6 | -12.1 | · | -12.6 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | · | 0.3 | 0.3 | 0.3 | · | 0.2 | 0.3 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | |
| Receivables Turnover | 1.5 | 1.1 | · | 1.7 | 1.3 | 1.2 | · | 0.9 | 1.1 | 1.4 | · | 1.0 | 1.1 | 1.1 | · | 1.5 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.50 | $0.60 | · | $0.81 | $0.96 | $0.36 | · | $0.73 | $1.01 | $1.15 | · | $1.62 | $1.89 | $2.14 | · | $3.45 | |
| Revenue / Share | $0.83 | $0.73 | · | $0.75 | $0.82 | $0.84 | · | $0.69 | $0.83 | $0.80 | · | $0.76 | $0.80 | $0.64 | · | $0.86 | |
| Cash Flow / Share | · | $-0.44 | · | · | · | $-0.57 | · | · | · | $-0.50 | · | · | · | $-0.56 | · | · | |
| Cash / Share | $1.02 | $0.89 | · | $1.58 | $1.37 | $0.62 | · | $1.26 | $1.41 | $1.57 | · | $1.68 | $1.87 | $3.10 | · | $4.21 | |
| EPS (TTM) | $-0.82 | $-0.90 | · | $-0.92 | $-0.89 | $-0.84 | · | $-0.94 | $-0.97 | $-1.09 | · | $-1.87 | $-2.03 | $-2.61 | · | $-2.33 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $71M | $68M | · | $64M | $59M | $57M | · | $56M | $57M | $56M | · | $52M | $53M | $46M | · | $45M | |
| Net Income TTM | $-19M | $-20M | · | $-19M | $-17M | $-16M | · | $-17M | $-17M | $-19M | · | $-32M | $-35M | $-45M | · | $-40M | |
| Market Cap | $112M | $72M | · | $247M | $154M | $64M | · | $54M | $32M | $28M | · | $41M | $49M | $41M | · | $44M | |
| Enterprise Value | $111M | $74M | · | $235M | $146M | $74M | · | $52M | $27M | $20M | · | $32M | $37M | $18M | · | $3M | |
| P/E | -5.7 | -3.3 | · | -11.9 | -7.8 | -4.3 | · | -3.3 | -1.9 | -1.5 | · | -1.3 | -1.4 | -0.9 | · | -1.2 | |
| P/S | 1.6 | 1.1 | · | 3.9 | 2.6 | 1.1 | · | 1.0 | 0.6 | 0.5 | · | 0.8 | 0.9 | 0.9 | · | 1.0 | |
| P/B | 9.2 | 5.0 | · | 13.6 | 7.3 | 10.1 | · | 4.2 | 1.8 | 1.4 | · | 1.5 | 1.5 | 1.1 | · | 0.8 | |
| P / Tangible Book | 9.2 | 5.0 | · | 13.6 | 7.3 | 10.1 | · | 4.2 | 1.8 | 1.4 | · | 1.5 | 1.5 | 1.1 | · | 0.9 | |
| P / Cash Flow | · | -6.9 | · | · | · | -6.0 | · | · | · | -3.0 | · | · | · | -4.2 | · | · | |
| EV / Revenue | 1.6 | 1.1 | · | 3.7 | 2.5 | 1.3 | · | 0.9 | 0.5 | 0.4 | · | 0.6 | 0.7 | 0.4 | · | 0.1 | |
| Earnings Yield | -17.6% | -30.0% | · | -8.4% | -12.8% | -23.4% | · | -30.4% | -53.3% | -68.5% | · | -77.3% | -70.0% | -107.4% | · | -86.0% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-06-30 |
|---|---|---|---|---|---|
| Revenue | $67M | $56M | $53M | $46M | · |
| Gross Margin % | 58.3% | 59.5% | · | · | · |
| Operating Margin % | -21.1% | -24.5% | -43.5% | -101.1% | · |
| Net Income | $-20M | $-15M | $-24M | $-47M | · |
| Diluted EPS | $-0.93 | $-0.83 | $-1.34 | $-2.77 | · |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-06-30 |
|---|---|---|---|---|---|
| Debt / Equity | 1.3 | 2.1 | 0.9 | 0.7 | · |
| Current Ratio | 3.5 | 2.7 | 4.0 | 7.5 | · |
| Quick Ratio | 3.0 | 2.2 | 3.6 | 7.1 | · |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-06-30 |
|---|---|---|---|---|---|
| Free Cash Flow | $-14M | $-14M | $-15M | $-36M | · |
Institutional owners (13F) 60 filers · $40.2M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
60
Value held
$40.2M
New positions
8
Exited positions
11
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 8 (0 vs prior Q) | 11 (-12 vs prior Q) | 15 (-10 vs prior Q) | 24 (+2 vs prior Q) | -1.7M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| VANGUARD GROUP INC | $4,803,267 | 790,011 | 11.94% | Shares |
| WEXFORD CAPITAL LP | $3,686,776 | 792,855 | 9.16% | Shares |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | $3,138,750 | 675,000 | 7.80% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $2,849,669 | 612,832 | 7.08% | Shares |
| FourWorld Capital Management LLC | $2,773,855 | 596,528 | 6.89% | Shares |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $2,393,639 | 514,761 | 5.95% | Shares |
| KENNEDY CAPITAL MANAGEMENT LLC | $2,255,473 | 485,048 | 5.61% | Shares |
| Mink Brook Asset Management LLC | $2,213,140 | 475,944 | 5.50% | Shares |
| JANE STREET GROUP, LLC | $1,499,635 | 322,502 | 3.73% | Shares |
| First Eagle Investment Management, LLC | $1,427,387 | 306,965 | 3.55% | Shares |
| MARSHALL WACE, LLP | $1,426,169 | 306,703 | 3.54% | Shares |
| FLPUTNAM INVESTMENT MANAGEMENT CO | $1,342,967 | 288,810 | 3.34% | Shares |
| TWO SIGMA ADVISERS, LP | $978,880 | 161,000 | 2.43% | Shares |
| RTW INVESTMENTS, LP | $906,750 | 195,000 | 2.25% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $863,873 | 185,654 | 2.15% | Shares |
| Man Group plc | $777,908 | 167,292 | 1.93% | Shares |
| BlackRock, Inc. | $663,206 | 142,625 | 1.65% | Shares |
| PERCEPTIVE ADVISORS LLC | $534,252 | 114,893 | 1.33% | Shares |
| XTX Topco Ltd | $520,558 | 111,948 | 1.29% | Shares |
| SEI INVESTMENTS CO | $506,873 | 109,005 | 1.26% | Shares |
| Squarepoint Ops LLC | $506,817 | 108,993 | 1.26% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $505,218 | 108,649 | 1.26% | Shares |
| GWN SECURITIES INC. | $362,858 | 78,034 | 0.90% | Shares |
| STATE STREET CORP | $331,340 | 71,256 | 0.82% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $290,986 | 62,571 | 0.72% | Shares |
| TWO SIGMA INVESTMENTS, LP | $278,963 | 59,992 | 0.69% | Shares |
| PERKINS CAPITAL MANAGEMENT INC | $264,101 | 56,796 | 0.66% | Shares |
| GOLDMAN SACHS GROUP INC | $242,181 | 52,082 | 0.60% | Shares |
| D. E. Shaw & Co., Inc. | $231,161 | 49,712 | 0.57% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $184,140 | 39,600 | 0.46% | Shares |
| NORTHERN TRUST CORP | $183,735 | 39,513 | 0.46% | Shares |
| Engineers Gate Manager LP | $172,050 | 37,000 | 0.43% | Shares |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $139,509 | 30,002 | 0.35% | Shares |
| AXQ CAPITAL, LP | $129,958 | 27,948 | 0.32% | Shares |
| R Squared Ltd | $121,239 | 26,073 | 0.30% | Shares |
| Invesco Ltd. | $98,268 | 21,133 | 0.24% | Shares |
| Bank of New York Mellon Corp | $97,362 | 20,938 | 0.24% | Shares |
| Arax Advisory Partners | $97,269 | 20,918 | 0.24% | Shares |
| OCCUDO QUANTITATIVE STRATEGIES LP | $95,939 | 20,632 | 0.24% | Shares |
| CITADEL ADVISORS LLC | $66,927 | 14,393 | 0.17% | Shares |
| Jump Financial, LLC | $54,521 | 11,725 | 0.14% | Shares |
| Corient Private Wealth LP | $51,583 | 11,093 | 0.13% | Shares |
| MORGAN STANLEY | $29,472 | 6,338 | 0.07% | Shares |
| Truvestments Capital LLC | $26,314 | 5,659 | 0.07% | Shares |
| BARCLAYS PLC | $25,542 | 5,493 | 0.06% | Shares |
| Vanguard Global Advisers, LLC | $19,256 | 4,141 | 0.05% | Shares |
| UBS Group AG | $18,874 | 4,059 | 0.05% | Shares |
| Tower Research Capital LLC (TRC) | $13,801 | 2,968 | 0.03% | Shares |
| WELLS FARGO & COMPANY/MN | $11,100 | 2,387 | 0.03% | Shares |
| OSAIC HOLDINGS, INC. | $5,115 | 1,100 | 0.01% | Shares |
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| H.I.G. Bio-Exagen, L.P., H.I.G.-GPII, Inc., Anthony Tamer, Sami Mnaymneh | Feb. 24, 2021 | · | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 20 insiders · 3 officers · 6 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| John Aballi | President and CEO | March 12, 2026 A | 839,834 | 0 | 3 | $-473,811 |
| Jeffrey G. Black | Chief Financial Officer | Sept. 1, 2026 A | 324,910 | 0 | 2 | $-154,551 |
| Thierry Dervieux | Chief Scientific Officer | Sept. 18, 2019 A | · | 0 | 0 | $0 |
| Frank Stokes | Director | June 9, 2026 A | · | 0 | 0 | $0 |
| Chas Mckhann | Director | June 9, 2026 A | · | 0 | 0 | $0 |
| Bruce C Robertson | Director | June 9, 2026 A | · | 0 | 0 | $0 |
| Paul Kim | Director | June 9, 2026 A | · | 0 | 0 | $0 |
| Scott D Kahn | Director | June 9, 2026 A | · | 0 | 0 | $0 |
| Ana Hooker | · | June 10, 2025 A | · | 0 | 0 | $0 |
| Tina Susan Nova | · | June 10, 2025 A | · | 0 | 0 | $0 |
| Kamal Adawi | · | March 4, 2024 S | 243,749 | 0 | 0 | $0 |
| Wendy S. Johnson | · | June 9, 2023 A | 1,000 | 0 | 0 | $0 |
| Brian Birk | · | June 9, 2023 A | · | 0 | 0 | $0 |
| Ebetuel Pallares | · | June 9, 2023 A | 1,185 | 0 | 0 | $0 |
| Mark Hazeltine | · | March 2, 2023 S | 190,205 | 0 | 0 | $0 |
| James L L Tullis | · | June 16, 2022 A | 1,515,672 | 0 | 0 | $0 |
| Debra Zack | · | March 1, 2022 F | 84,259 | 0 | 0 | $0 |
| Fortunato R. Rocca | · | March 1, 2022 F | 120,678 | 0 | 0 | $0 |
| Chet Burrell | · | June 18, 2020 A | · | 0 | 0 | $0 |
| Jeffrey Thomas Elliott | · | June 18, 2020 A | · | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 8 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0.56% | 16,342 SH | Oct. 2, 2026 | Daily |
| IWC · iShares Trust | 0.03% | 55,590 SH | Sept. 11, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.00% | 25,070 NS | July 31, 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.00% | 3,419 NS | July 31, 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 1,831 NS | July 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 179,415 SH | Aug. 19, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 414,852 SH | Aug. 19, 2026 | Daily |
| DFAC · Dimensional ETF Trust | 0.00% | 3,498 NS | July 31, 2026 | N-PORT |
XGN Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 12 analysts
BUY
Median target
$10.00
+22.4%
3 25.0%
Strong Buy
8 66.7%
Buy
1 8.3%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
7 analysts · 2026-10-02Mean target $10.14 +24.1%
← Below all targets
Current price $8.17
Low$9.00
Mean$10.14
High$12.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| XGN | $139M | -6.5 | 19.7% | -30.0% | -103.7% | 58.3% |
| CRBP | $143M | -1.4 | · | · | -60.8% | · |
| UNCY | $128M | -3.5 | -29.0% | · | -113.9% | · |
| GNLX | $166M | -5.1 | 0.00% | -401812.5% | -181.4% | · |
| COYA | $121M | -4.6 | 123.6% | -267.1% | -59.5% | · |
| IMDX | $215M | -4.5 | 115.6% | -1238.5% | 330.8% | 56.7% |
| IMUX | · | -0.9 | · | · | · | · |
| BDTX | $139M | 6.2 | · | 31.9% | 18.3% | · |
| CADL | $310M | -7.8 | · | · | -53.7% | · |
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 4, 2026